KCa3.1 channels may interfere with resistance to chemotherapy of tumors as suggested by few studies showing that KCa3.1 function is required in human epidermoid cancer cells [14] and glioblastoma cells [25] for caspase activation following treatment with cisplatin and staurosporine, respectively. This evidence concerns the gene KCNN4 and glioblastoma.